Company Data
Cingulate Inc.
Ticker
CING
Current Price
$3.73 -6.52%
Market Cap
$20.2M
Price Target
Refer to Report
Volume
171.3K
52wk Range
$3.02 - $9.69
Overview
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.